T lymphocytes in atherogenesis - Functional aspects and antigenic repertoire

Cardiovascular Research

Volumn 60, Issue 1, 2003, Pages 78-86

  De Boer, Onno J ^a   Becker, Anton E ^a   Van Der Wal, Allard C ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Atherosclerosis; Cytokines; Immunology; Infection inflammation; T cells

Indexed keywords

ANTIGEN; APOLIPOPROTEIN E; CELL ADHESION MOLECULE; GAMMA INTERFERON; IMMUNOGLOBULIN; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 18; LIPID; RAG1 PROTEIN; RAG2 PROTEIN; HLA DR ANTIGEN;

ANTIGENICITY; APOPTOSIS; ARTERY INTIMA; ATHEROGENESIS; ATHEROSCLEROSIS; B LYMPHOCYTE; CELL POPULATION; CELL SUBPOPULATION; CELLULAR IMMUNITY; DISEASE COURSE; EPSTEIN BARR VIRUS; HELICOBACTER PYLORI; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MACROPHAGE; MICROORGANISM; MOLECULAR RECOGNITION; MONOCYTE; NONHUMAN; PLASMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; ARTERIOSCLEROSIS; ENDOTHELIUM CELL; HUMAN; IMMUNOLOGY; INFECTION; LYMPHOCYTE ACTIVATION; PHYSIOLOGY; VASCULAR ENDOTHELIUM;

ARTERIOSCLEROSIS; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; HLA-DR ANTIGENS; HUMANS; INFECTION; LYMPHOCYTE ACTIVATION; MACROPHAGES; T-LYMPHOCYTES;

EID: 0642281745     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(03)00341-9     Document Type: Review

References (85)

1. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med. 340:(2):1999;115-126.
2. van der Wal A.C., Becker A.E. Atherosclerotic plaque rupture - pathologic basis of plaque stability and instability. Cardiovasc Res. 41:(2):1999;334-344.
3. Hansson G.K. Immune mechanisms in atherosclerosis. Arterioscler Thromb Vasc Biol. 21:(12):2001;1876-1890.
4. Hansson G.K., Libby P., Schonbeck U., Yan Z.Q. Innate and adaptive immunity in the pathogenesis of atherosclerosis. Circ Res. 91:(4):2002;281-291.
5. Libby P., Schoenbeck U., Mach F., Selwyn A.P., Ganz P. Current concepts in cardiovascular pathology: the role of LDL cholesterol in plaque rupture and stabilization. Am J Med. 104:(2A):1998;14S-18S.
6. Jonasson L., Holm J., Skalli O., Bondjers G., Hansson G.K. Regional accumulations of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque. Arteriosclerosis. 6:(2):1986;131-138.
7. van der Wal A.C., Das P.K., Bentz van de Berg D., van der Loos C.M., Becker A.E. Atherosclerotic lesions in humans. In situ immunophenotypic analysis suggesting an immune mediated response. Lab Invest. 61:(2):1989;166-170.
8. Stemme S., Holm J., Hansson G.K. T lymphocytes in human atherosclerotic plaques are memory cells expressing CD45RO and the integrin VLA-1. Arterioscler Thromb. 12:(2):1992;206-211.
9. Caligiuri G., Nicoletti A., Poirier B., Hansson G.K. Protective immunity against atherosclerosis carried by B cells of hypercholesterolemic mice. J Clin Invest. 109:(6):2002;745-753.
10. Major A.S., Fazio S., Linton M.F. B-lymphocyte deficiency increases atherosclerosis in LDL receptor-null mice. Arterioscler Thromb Vasc Biol. 22:(11):2002;1892-1898.
11. Hansson G.K., Holm J., Jonasson L. Detection of activated T lymphocytes in the human atherosclerotic plaque. Am J Pathol. 135:(1):1989;169-175.
12. Howard J.C. Supply and transport of peptides presented by class I MHC molecules. Curr Opin Immunol. 7:(1):1995;69-76.
13. Abbas A.K., Murphy K.M., Sher A. Functional diversity of helper T lymphocytes. Nature. 383:(6603):1996;787-793.
14. O'Garra A., Steinman L., Gijbels K. CD4+ T-cell subsets in autoimmunity. Curr Opin Immunol. 9:(6):1997;872-883.
15. Groux H., O'Garra A., Bigler M., et al. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature. 389:(6652):1997;737-742.
16. Dansky H.M., Charlton S.A., Harper M.M., Smith J.D. T and B lymphocytes play a minor role in atherosclerotic plaque formation in the apolipoprotein E-deficient mouse. Proc Natl Acad Sci USA. 94:(9):1997;4642-4646.
17. Zhou X., Nicoletti A., Elhage R., Hansson G.K. Transfer of CD4(+) T cells aggravates atherosclerosis in immunodeficient apolipoprotein E knockout mice. Circulation. 102:(24):2000;2919-2922.
18. de Boer O.J., van der Wal A.C., Teeling P., Becker A.E. Leucocyte recruitment in rupture prone regions of lipid-rich plaques: a prominent role for neovascularization? Cardiovasc Res. 41:1999;443-449.
19. Paulsson G., Zhou X., Tornquist E., Hansson G.K. Oligoclonal T cell expansions in atherosclerotic lesions of apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol. 20:(1):2000;10-17.
20. Stemme S., Rymo L., Hansson G.K. Polyclonal origin of T lymphocytes in human atherosclerotic plaques. Lab Invest. 65:(6):1991;654-660.
21. Uyemura K., Demer L.L., Castle S.C., et al. Cross-regulatory roles of interleukin (IL)-12 and IL-10 in atherosclerosis. J Clin Invest. 97:(9):1996;2130-2138.
22. Frostegård J., Ulfgren A.K., Nyberg P., et al. Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (Th1) and macrophage stimulating cytokines. Atherosclerosis. 145:1999;33-43.
23. de Boer O.J., van der Wal A.C., Verhagen C.E., Becker A.E. Cytokine secretion profiles of cloned T cells from human aortic atherosclerotic plaques. J Pathol. 188:1999;174-179.
24. Gupta S., Pablo A.M., Jiang X., Wang N., Tall A.R., Schindler C. IFN-gamma potentiates atherosclerosis in ApoE knock-out mice. J Clin Invest. 99:(11):1997;2752-2761.
25. Whitman S.C., Ravisankar P., Elam H., Daugherty A. Exogenous interferon-gamma enhances atherosclerosis in apolipoprotein E-/- mice. Am J Pathol. 157:(6):2000;1819-1824.
26. Laurat E., Poirier B., Tupin E., et al. In vivo downregulation of T helper cell 1 immune responses reduces atherogenesis in apolipoprotein E-knockout mice. Circulation. 104:(2):2001;197-202.
27. Pinderski L.J., Fischbein M.P., Subbanagounder G., et al. Overexpression of interleukin-10 by activated T lymphocytes inhibits atherosclerosis in LDL receptor-deficient Mice by altering lymphocyte and macrophage phenotypes. Circ Res. 90:(10):2002;1064-1071.
28. Jeziorska M., Woolley D.E. Local neovascularization and cellular composition within vulnerable regions of atherosclerotic plaques of human carotid arteries. J Pathol. 188:(2):1999;189-196.
29. Kaartinen M., Penttila A., Kovanen P.T. Mast cells accompany microvessels in human coronary atheromas: implications for intimal neovascularization and hemorrhage. Atherosclerosis. 123:(1-2):1996;123-131.
30. van der Wal A.C., Becker A.E., van der Loos C.M., Das P.K. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation. 89:(1):1994;36-44.
31. van der Wal A.C., Piek J.J., de Boer O.J., et al. Recent activation of the plaque immune response in coronary lesions underlying acute coronary syndromes. Heart. 80:(1):1998;14-18.
32. Hosono M, de Boer OJ, van der Wal AC, et al. Increased expression of T cell activation markers (CD25, CD26, CD40L and CD69) in atherectomy specimens of patients with unstable angina and acute myocardial infarction. Atherosclerosis 2003; in press.
33. Jonasson L., Linderfalk C., Olsson J., Wikby A., Olsson A.G. Systemic T-cell activation in stable angina pectoris. Am J Cardiol. 89:(6):2002;754-756.
34. Neri Serneri G.G., Prisco D., Martini F., et al. Acute T-cell activation is detectable in unstable angina. Circulation. 95:(7):1997;1806-1812.
35. Porsch-Oezcueruemez M., Kunz D., Kloer H.U., Luley C. Evaluation of serum levels of solubilized adhesion molecules and cytokine receptors in coronary heart disease. J Am Coll Cardiol. 34:(7):1999;1995-2001.
36. Aukrust P., Mu F., Ueland T., et al. Enhanced levels of soluble and membrane-bound CD40 ligand in patients with unstable angina. Possible reflection of T lymphocyte and platelet involvement in the pathogenesis of acute coronary syndromes. Circulation. 100:(6):1999;614-620.
37. Peng D.Q., Zhao S.P., Li Y.F., Li J., Zhou H.N. Elevated soluble CD40 ligand is related to the endothelial adhesion molecules in patients with acute coronary syndrome. Clin Chim Acta. 319:(1):2002;19-26.
38. Liuzzo G., Kopecky S.L., Frye R.L., et al. Perturbation of the T-cell repertoire in patients with unstable angina. Circulation. 100:(21):1999;2135- 2139.
39. Wilkinson P.C., Liew F.Y. Chemoattraction of human blood T lymphocytes by interleukin-15. J Exp Med. 181:(3):1995;1255-1259.
40. Kanegane H., Tosato G. Activation of naive and memory T cells by interleukin-15. Blood. 88:(1):1996;230-235.
41. Borger P., Kauffman H.F., Postma D.S., Esselink M.T., Vellenga E. Interleukin-15 differentially enhances the expression of interferon-gamma and interleukin-4 in activated human (CD4+) T lymphocytes. Immunology. 96:(2):1999;207-214.
42. Houtkamp M.A., van Der Wal A.C., de Boer O.J., et al. Interleukin-15 expression in atherosclerotic plaques: an alternative pathway for T-cell activation in atherosclerosis? Arterioscler Thromb Vasc Biol. 21:(7):2001;1208-1213.
43. Davies M.J., Richardson P.D., Woolf N., Katz D.R., Mann J. Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content. Br Heart J. 69:(5):1993;377-381.
44. Stemme S., Faber B., Holm J., Wiklund O., Witztum J.L., Hansson G.K. T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein. Proc Natl Acad Sci USA. 92:(9):1995;3893-3897.
45. George J., Harats D., Gilburd B., et al. Adoptive transfer of {beta}2-glycoprotein I-reactive lymphocytes enhances early atherosclerosis in LDL receptor-deficient mice. Circulation. 102:(15):2000;1822-1827.
46. Sherer Y., Shoenfeld Y. Antiphospholipid syndrome, antiphospholipid antibodies, and atherosclerosis. Curr Atheroscler Rep. 3:(4):2001;328-333.
47. George J., Harats D., Gilburd B., Levy Y., Langevitz P., Shoenfeld Y. Atherosclerosis-related markers in systemic lupus erythematosus patients: the role of humoral immunity in enhanced atherogenesis. Lupus. 8:(3):1999;220-226.
48. Saikku P., Leinonen M., Mattila K., et al. Serological evidence of an association of a novel Chlamydia TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet. 2:(8618):1988;983-986.
49. Ossei-Gerning N., Moayyedi P., Smith S., et al. Helicobacter pylori infection is related to atheroma in patients undergoing coronary angiography. Cardiovasc Res. 35:(1):1997;120-124.
50. Beck J.D., Offenbacher S., Williams R., Gibbs P., Garcia R. Periodontitis: a risk factor for coronary heart disease? Ann Periodontol. 3:(1):1998;127-141.
51. Adam E., Melnick J.L., Probtsfield J.L., et al. High levels of cytomegalovirus antibody in patients requiring vascular surgery for atherosclerosis. Lancet. 2:(8554):1987;291-293.
52. Zhu J., Quyyumi A.A., Norman J.E., Costello R., Csako G., Epstein S.E. The possible role of hepatitis A virus in the pathogenesis of atherosclerosis. J Infect Dis. 182:(6):2000;1583-1587.
53. Roivainen M., Alfthan G., Jousilahti P., Kimpimaki M., Hovi T., Tuomilehto J. Enterovirus infections as a possible risk factor for myocardial infarction. Circulation. 98:(23):1998;2534-2537.
54. Musiani M., Zerbini M.L., Muscari A., et al. Antibody patterns against cytomegalovirus and Epstein-Barr virus in human atherosclerosis. Microbiologica. 13:(1):1990;35-41.
55. Rupprecht H.J., Blankenberg S., Bickel C., et al. Impact of viral and bacterial infectious burden on long-term prognosis in patients with coronary artery disease. Circulation. 104:(1):2001;25-31.
56. Zhu J.H., Quyyumi A.A., Norman J.E., et al. Effects of total pathogen burden on coronary artery disease risk and C-reactive protein levels. Am J Cardiol. 85:(2):2000;140-146.
57. de Boer O.J., van Der Wal A.C., Becker A.E. Atherosclerosis, inflammation, and infection. J Pathol. 190:(3):2000;237-243.
58. Morre S.A., Stooker W., Lagrand W.K., van den Brule A.J., Niessen H.W. Microorganisms in the aetiology of atherosclerosis. J Clin Pathol. 53:(9):2000;647-654.
59. Muhlestein J.B., Hammond E.H., Carlquist J.F., et al. Increased incidence of Chlamydia species within the coronary arteries of patients with symptomatic atherosclerotic versus other forms of cardiovascular disease. J Am Coll Cardiol. 27:(7):1996;1555-1561.
60. Kuo C.C., Shor A., Campbell L.A., Fukushi H., Patton D.L., Grayston J.T. Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries. J Infect Dis. 167:(4):1993;841-849.
61. Maass M., Bartels C., Engel P.M., Mamat U., Sievers H.H. Endovascular presence of viable Chlamydia pneumoniae is a common phenomenon in coronary artery disease. J Am Coll Cardiol. 31:(4):1998;827-832.
62. Moazed T.C., Campbell L.A., Rosenfeld M.E., Grayston J.T., Kuo C.C. Chlamydia pneumoniae infection accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice. J Infect Dis. 180:(1):1999;238-241.
63. Ezzahiri R., Nelissen-Vrancken H.J., Kurvers H.A., et al. Chlamydophila pneumoniae (Chlamydia pneumoniae) accelerates the formation of complex atherosclerotic lesions in Apo E3-Leiden mice. Cardiovasc Res. 56:(2):2002;269.
64. de Boer O.J., van der Wal A.C., Houtkamp M.A., Ossewaarde J.M., Teeling P., Becker A.E. Unstable atherosclerotic plaques contain T-cells that respond to chlamydia pneumoniae. Cardiovasc Res. 48:(3):2000;402-408.
65. Curry A.J., Portig I., Goodall J.C., Kirkpatrick P.J., Gaston J.S.H. T lymphocyte lines isolated from atheromatous plaque contain cells capable of responding to Chlamydia antigens. Clin Exp Immunol. 121:(2):2000;261-269.
66. Mosorin M., Surcel H.M., Laurila A., et al. Detection of Chlamydia pneumoniae-reactive T lymphocytes in human atherosclerotic plaques of carotid artery. Arterioscler Thromb Vasc Biol. 20:(4):2000;1061-1067.
67. Halme S., Juvonen T., Laurila A., et al. Chlamydia pneumoniae reactive T lymphocytes in the walls of abdominal aortic aneurysms. Eur J Clin Invest. 29:(6):1999;546-552.
68. Mattila K.J., Nieminen M.S., Valtonen V.V., et al. Association between dental health and acute myocardial infarction. Br Med J. 298:(6676):1989;779- 781.
69. Haraszthy V.I., Zambon J.J., Trevisan M., Zeid M., Genco R.J. Identification of periodontal pathogens in atheromatous plaques. J Periodontol. 71:(10):2000;1554-1560.
70. Choi J.I., Chung S.W., Kang H.S., Rhim B.Y., Kim S.J. Establishment of Porphyromonas gingivalis heat-shock-protein-specific T-cell lines from atherosclerosis patients. J Dent Res. 81:(5):2002;344-348.
71. Shi Y., Tokunaga O. Herpesvirus (HSV-1, EBV and CMV) infections in atherosclerotic compared with non-atherosclerotic aortic tissue. Pathol Int. 52:(1):2002;31-39.
72. de Boer O.J., Teeling P., Becker A.E., van Der Wal A.C. T lymphocytes specific for Epstein-Barr virus are present in human unstable atherosclerotic plaques. Circulation. 19:2002;202A.
73. Xu Q. Role of heat shock proteins in atherosclerosis. Arterioscler Thromb Vasc Biol. 22:(10):2002;1547-1559.
74. Xu Q., Kleindienst R., Waitz W., Dietrich H., Wick G. Increased expression of heat shock protein 65 coincides with a population of infiltrating T lymphocytes in atherosclerotic lesions of rabbits specifically responding to heat shock protein 65. J Clin Invest. 91:(6):1993;2693-2702.
75. Kaul R., Uphoff J., Wiedeman J., Yadlapalli S., Wenman W.M. Detection of Chlamydia pneumoniae DNA in CD3+ lymphocytes from healthy blood donors and patients with coronary artery disease. Circulation. 102:(19):2000;2341-2346.
76. Bonneville M., Scotet E., Peyrat M.A., Saulquin X., Houssaint E. Epstein-Barr virus and rheumatoid arthritis. Rev Rhum Engl Ed. 65:(6):1998;365-368.
77. Braun J., Laitko S., Treharne J., et al. Chlamydia pneumoniae - a new causative agent of reactive arthritis and undifferentiated oligoarthritis. Ann Rheumatic Dis. 53:(2):1994;100-105.
78. Krause A., Kamradt T., Burmester G.R. Potential infectious agents in the induction of arthritides. Curr Opin Rheumatol. 8:(3):1996;203-209.
79. King L.E. Jr., Stratton C.W., Mitchell W.M. Chlamydia pneumoniae and chronic skin wounds: a focused review. J Invest Dermatol Symp Proc. 6:(3):2001;233-237.
80. Reardon C.A., Blachowicz L., White T., et al. Effect of immune deficiency on lipoproteins and atherosclerosis in male apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol. 21:(6):2001;1011-1016.
81. Mallat Z., Besnard S., Duriez M., et al. Protective role of interleukin-10 in atherosclerosis. Circ Res. 85:(8):1999;e17-24.
82. King V.L., Szilvassy S.J., Daugherty A. Interleukin-4 deficiency decreases atherosclerotic lesion formation in a site-specific manner in female LDL receptor-/- mice. Arterioscler Thromb Vasc Biol. 22:(3):2002;456-461.
83. Lutgens E., Gorelik L., Daemen M.J., et al. Requirement for CD154 in the progression of atherosclerosis. Nat Med. 5:(11):1999;1313-1316.
84. Lee T.S., Yen H.C., Pan C.C., Chau L.Y. The role of interleukin 12 in the development of atherosclerosis in ApoE-deficient mice. Arterioscler Thromb Vasc Biol. 19:(3):1999;734-742.
85. Whitman S.C., Ravisankar P., Daugherty A. Interleukin-18 enhances atherosclerosis in apolipoprotein E(-/-) mice through release of interferon-gamma. Circ Res. 90:(2):2002;E34-E38.